FDA panel endorses first-of-a-kind cancer blood test from GrailA federal health panel has endorsed an experimental cancer test that uses a blood sample to detect multiple forms of the disease. The vote Wednesday from a panel of Food and Drug Administration advisers could pave the way for broader adoption and insurance coverage of the test from manufacturer Grail Inc. The positive vote came despite many lingering…The Atlanta Journal-Constitution13d agoWhole story →HealthJusticefda panel vote
